ArticlePloS one2022

SGLT2 inhibitors therapy protects glucotoxicity-induced β-cell failure in a mouse model of human KATP-induced diabetes through mitigation of oxidative and ER stress.

Zeenat A Shyr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.